Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors

Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206–12. https://doi.org/10.1111/j.1365-4632.2011.05377.x.

Article  Google Scholar 

Taïeb A, Picardo M. Clinical practice Vitiligo. N Engl J Med. 2009;360(2):160–9. https://doi.org/10.1056/NEJMcp0804388.

Article  Google Scholar 

Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473–91. https://doi.org/10.1016/j.jaad.2010.11.061.

Article  Google Scholar 

Sehgal VN, Srivastava G. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73(3):149–56. https://doi.org/10.4103/0378-6323.32708.

Article  Google Scholar 

Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013;149(2):159–64. https://doi.org/10.1001/jamadermatol.2013.927.

Article  Google Scholar 

Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris JE, Hamzavi IH, Pandya AG, Vitiligo Working Group. Vitiligo is not a cosmetic disease. J Am Acad Dermatol. 2015;73(5):883–5. https://doi.org/10.1016/j.jaad.2015.07.039.

Article  Google Scholar 

Ezzedine K, Grimes PE, Meurant JM, Seneschal J, Léauté-Labrèze C, Ballanger F, Jouary T, Taïeb C, Taïeb A. Living with vitiligo: results from a national survey indicate differences between skin phototypes. Br J Dermatol. 2015;173(2):607–9. https://doi.org/10.1111/bjd.13839.

Article  CAS  Google Scholar 

Osinubi O, Grainge MJ, Hong L, Ahmed A, Batchelor JM, Grindlay D, Thompson AR, Ratib S. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2018;178(4):863–78. https://doi.org/10.1111/bjd.16049.

Article  CAS  Google Scholar 

Hamidizadeh N, Ranjbar S, Ghanizadeh A, Parvizi MM, Jafari P, Handjani F. Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population. Health Qual Life Outcomes. 2020;18(1):20. https://doi.org/10.1186/s12955-020-1278-7.

Article  Google Scholar 

Bae JM, Kim JE, Lee RW, Ju HJ, Han JH, Lee JH, Woo YR, Lee JH, Bang CH, Park CJ, Ezzedine K, Kim M. Beyond quality of life: a call for patients’ own willingness to pay in chronic skin disease to assess psychosocial burden—a multicenter, cross-sectional, prospective survey. J Am Acad Dermatol. 2021;85(5):1321–4. https://doi.org/10.1016/j.jaad.2020.09.088.

Article  Google Scholar 

Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, Goh BK, Anbar T. Vitiligo Global Issue Consensus Conference Panelists. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25(3):E1–13. https://doi.org/10.1111/j.1755-148X.2012.00997.x.

Article  CAS  Google Scholar 

Taïeb A, Picardo M, VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20(1):27–35. https://doi.org/10.1111/j.1600-0749.2006.00355.x.

Article  Google Scholar 

Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J, Young K, Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists; Clinical Standards Department, Royal College of Physicians of London; Cochrane Skin Group. Vitiligo Society Guideline for the diagnosis and management of vitiligo. Br J Dermatol. 2008;159(5):1051–76. https://doi.org/10.1111/j.1365-2133.2008.08881.x.

Article  CAS  Google Scholar 

Taieb A, Alomar A, Böhm M, Dell’anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M, Vitiligo European Task Force (VETF); European Academy of Dermatology and Venereology (EADV); Union Europeenne des MedecinsSpecialistes (UEMS). Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168(1):5–19. https://doi.org/10.1111/j.1365-2133.2012.11197.x.

Article  CAS  Google Scholar 

Oiso N, Suzuki T, Wataya-Kaneda M, Tanemura A, Tanioka M, Fujimoto T, Fukai K, Kawakami T, Tsukamoto K, Yamaguchi Y, Sano S, Mitsuhashi Y, Nishigori C, Morita A, Nakagawa H, Mizoguchi M, Katayama I. Guidelines for the diagnosis and treatment of vitiligo in Japan. J Dermatol. 2013;40(5):344–54. https://doi.org/10.1111/1346-8138.12099.

Article  CAS  Google Scholar 

Esmat SM, El-Tawdy AM, Hafez GA, Zeid OA, Abdel Halim DM, Saleh MA, Leheta TM, Elmofty M. Acral lesions of vitiligo: why are they resistant to photochemotherapy? J Eur Acad Dermatol Venereol. 2012;26(9):1097–104. https://doi.org/10.1111/j.1468-3083.2011.04215.x.

Article  CAS  Google Scholar 

Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J, Young K. Vitiligo: concise evidence based guidelines on diagnosis and management. Postgrad Med J. 2010;86(1018):466–71. https://doi.org/10.1136/pgmj.2009.093278.

Article  Google Scholar 

Whitton ME, Pinart M, Batchelor J, Lushey C, Leonardi-Bee J, González U. Interventions for vitiligo. Cochrane Database Syst Rev. 2010;1: CD003263. https://doi.org/10.1002/14651858.CD003263.pub4.

Article  Google Scholar 

Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, González U, Jiyad Z, Eleftheriadou V, Ezzedine K. Interventions for vitiligo. Cochrane Database Syst Rev. 2015;2: CD003263. https://doi.org/10.1002/14651858.CD003263.pub5.

Article  Google Scholar 

Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, Eleftheriadou V, Ezzedine K. Evidence-based management of vitiligo: summary of a Cochrane systematic review. Br J Dermatol. 2016;174(5):962–9. https://doi.org/10.1111/bjd.14356.

Article  CAS  Google Scholar 

Picardo M, Dell’Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Vitiligo. Nat Rev Dis Primers. 2015;1:15011. https://doi.org/10.1038/nrdp.2015.11.

Article  Google Scholar 

Spritz RA, Andersen GH. Genetics of Vitiligo. Dermatol Clin. 2017;35(2):245–55. https://doi.org/10.1016/j.det.2016.11.013.

Article  CAS  Google Scholar 

Spritz RA. Modern vitiligo genetics sheds new light on an ancient disease. J Dermatol. 2013;40(5):310–8. https://doi.org/10.1111/1346-8138.12147.

Article  CAS  Google Scholar 

Spritz RA. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid. 2010;20(7):745–54. https://doi.org/10.1089/thy.2010.1643.

Article  CAS  Google Scholar 

Czajkowski R, Męcińska-Jundziłł K. Current aspects of vitiligo genetics. Postepy Dermatol Alergol. 2014;31(4):247–55. https://doi.org/10.5114/pdia.2014.43497.

Article  Google Scholar 

Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007;356(12):1216–25. https://doi.org/10.1056/NEJMoa061592.

Article  CAS  Google Scholar 

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJ, Hutton SM, Amadi-Myers A, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med. 2010;362(18):1686–97. https://doi.org/10.1056/NEJMoa0908547.

Article  CAS  Google Scholar 

Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S, Brownson KM, Holland PJ, Birlea SA, Siebert J, Hartmann A, Lienert A, van Geel N, Lambert J, Luiten RM, Wolkerstorfer A, Wietze van der Veen JP, Bennett DC, Taïeb A, Ezzedine K, Kemp EH, Gawkrodger DJ, Weetman AP, Kõks S, Prans E, Kingo K, Karelson M, Wallace MR, McCormack WT, Overbeck A, Moretti S, Colucci R, Picardo M, Silverberg NB, Olsson M, Valle Y, Korobko I, Böhm M, Lim HW, Hamzavi I, Zhou L, Mi QS, Fain PR, Santorico SA, Spritz RA. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet. 2016;48(11):1418–24. https://doi.org/10.1038/ng.3680.

Article  CAS  Google Scholar 

Jin Y, Birlea SA, Fain PR, Mailloux CM, Riccardi SL, Gowan K, Holland PJ, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA. Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet. 2010;42(7):576–8. https://doi.org/10.1038/ng.602.

Article  CAS  Google Scholar 

Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, Cole JB, Gowan K, Holland PJ, Bennett DC, Luiten RM, Wolkerstorfer A, van der Veen JP, Hartmann A, Eichner S, Schuler G, van Geel N, Lambert J, Kemp EH, Gawkrodger DJ, Weetman AP, Taïeb A, Jouary T, Ezzedine K, Wallace MR, McCormack WT, Picardo M, Leone G, Overbeck A, Silverberg NB, Spritz RA. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44(6):676–80. https://doi.org/10.1038/ng.2272.

Article  CAS  Google Scholar 

Spritz RA. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med. 2010;2(10):78. https://doi.org/10.1186/gm199.

Article  CAS  Google Scholar 

Birlea SA, Jin Y, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Fain PR, Spritz RA. Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Investig Dermatol. 2011;131(2):371–81. https://doi.org/10.1038/jid.2010.337.

Article  CAS  Google Scholar 

Spritz RA. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J Investig Dermatol. 2012;132(2):268–73. https://doi.org/10.1038/jid.2011.321.

Article  CAS  Google Scholar 

Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16(3):208–14. https://doi.org/10.1034/j.1600-0749.2003.00032.x.

Article  Google Scholar 

Millington GW, Levell NJ. Vitiligo: the historical curse of depigmentation. Int J Dermatol. 2007;46(9):990–5. https://doi.org/10.1111/j.1365-4632.2007.03195.x.

Article  Google Scholar 

Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet. 1994;55(5):981–90.

CAS  Google Scholar 

Dell’Anna ML, Maresca V, Briganti S, Camera E, Falchi M, Picardo M. Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Investig Dermatol. 2001;117(4):908–13. https://doi.org/10.1046/j.0022-202x.2001.01459.x.

Article  CAS  Google Scholar 

Maresca V, Roccella M, Roccella F, Camera E, Del Porto G, Passi S, Grammatico P, Picardo M. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Investig Dermatol. 1997;109(3):310–3. https://doi.org/10.1111/1523-1747.ep12335801.

Article  CAS  Google Scholar 

Jimbow K, Chen H, Park JS, Thomas PD. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol. 2001;144(1):55–65. https://doi.org/10.1046/j.1365-2133.2001.03952.x.

Article  CAS 

留言 (0)

沒有登入
gif